Results
3
Companies with a Future performance score of at least 3, ordered by Future performance score.
3 companies
PharmaEssentia
Market Cap: NT$164.9b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$497.00
7D
3.0%
1Y
58.3%
Caliway Biopharmaceuticals
Market Cap: NT$91.4b
Caliway Biopharmaceuticals Co.Ltd develops small molecule drugs for medical aesthetic and inflammatory disease.
6919
NT$629.00
7D
-10.5%
1Y
61.3%
Bora Pharmaceuticals
Market Cap: NT$70.4b
Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
6472
NT$687.00
7D
10.3%
1Y
-13.6%